Economic burden of antibiotic resistance
Today, one of my studies was published. The title of the study was “Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of […]
My Papers
Are caregivers ready for digital?
That is the title of a paper published today with my co-authors Felicia Forma, Kevin Chiu, Jason Shafrin, Dusica Hadzi Boskovic, and S Phani Veeranki. […]
Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy
That is the title of my recent paper in Advances in Therapy along with co-authors Christian Jackisch, Federico Manevy, Suzanne Frank, and Nicki Roberts. This […]
My ISPOR Europe 2021 Panels
If you are attending the ISPOR Europe 2021 conference, please check out my panels on the following topics: “Addressing Payment Challenges for Alzheimer’s Disease-Modifying Therapies” […]
ISPOR Europe Panels
Mark your calendars and be sure to register: I will be speaking on two panels at the upcoming ISPOR Europe 2021 virtual conference. These panels […]
USC’s Healthcare Decision Analysis Program
This Sunday I had a very enjoyable experience giving a guest lecture at the University of Southern California’s Healthcare Decision Analysis program (specifically class HCDA […]
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
That is the title of a recent commentary published in the Journal of Clinical Pathways with my colleague David Gruber. New digital technologies have the […]
Quantifying spillover benefits in value assessment
That is the title of a recent paper published in the Journal of Medical Economics with Syvart Dennan, Oliver Diaz, Kelly Birch, Jennifer Cai, Jennifer […]
Total Cost of Schizophrenia in the US was nearly $300 billion in 2020
That is the finding from a white paper from the Schizophrenia and Psychosis Action Alliance titled “Societal Costs of Schizophrenia & Related Disorders“. I am […]
Wall Street Journal’s Global Food Forum
I will be on a panel tomorrow for the Wall Street Journal‘s Global Food Forum. My panel will include and Hakim Bouzamondo (Divisional VP, Global […]
Should supply chain quality inform treatment value?
In an article in Health Affairs, Rick van der Vegte and I argue that in four specific cases, the answer is yes. …the International Society […]
When Should You Trust Your Doctor?
That is the title of a recent study I published with Michael Halasy in Mayo Clinic Proceedings. The subtitle is Establishing a Theoretical Model to […]
Measuring the Value Healthy Individuals Place on Generous Insurance Coverage of Severe Diseases
That is the title of a paper I just published at Value in Health with Suepattra G. May, Lauren M. Zhao, Katalin Bognar, Yong Yuan, […]
For which diseases do broader value elements matter most?
This is the question I–along with co-authors Syvart Dennen, Priti Pednekar , Kelly Birch, Menaka Bhor, Julie Kanter , and Peter Neumann–aim to answer in […]
How do pain crises affect quality of life and productivity among patients with sickle cell disease?
I provide the answer to this question in a recent paper in Current Medical Research & Opinion with co-authors Howard Thom, Edna Keeney, Daisy Gaunt, […]
Adoption of Digital Health Technologies in the Practice of Behavioral Health
This is the title of a paper published today with co-authors Suepattra May, Caroline Huber, Meaghan Roach, Wade Aubry, Darius Lakdawalla, John Kane, and Felicia […]
COVID-19 and Reductions in Cancer Mortality
That is the topic of a commentary I wrote with co-authors Joanna MacEwan and Farzad Ali, titled “Does COVID-19 Threaten the Progress Pharmaceuticals Have Made […]
ISPOR Europe Panel: “Will COVID-19 Accelerate the Adoption of Digital Health Technologies?”
Tomorrow, Monday, November 16 at 15:00 CET (9:00 EST/6:00 PST), I will be on an ISPOR Europe Panel titled “Will COVID-19 Accelerate the Adoption of […]
New cancer drugs saved 1.3 million lives
That is the finding from a recent paper by myself and co-authors Joanna MacEwan, Syvart Dennen, Rebecca Kee, Farzad Ali, and Katharine Batt. An excerpt […]
Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes
That is the title of an article in AJMC co-authored with Meena Venkatachalam. An excerpt is below: While decision-makers traditionally have ignored the issue of […]
Alternative payment models and innovation
I’m very excited to announce that the study: “Alternative payment models and innovation: A case study of US health system adoption of a sacubitril/valsartan to […]
Creating Incentives To Narrow The Gap In Health Outcomes
That is the title of my recent blog post in Health Affairs with my co-author Meena Venkatachalam. The subtitle is “Expanding Value Assessment To Incorporate […]
